FDA publishes complete response letter rejecting Summit's lung cancer drug
Published 2 d ago1 sourceEvidence: Reported
The FDA is again seeking a new commissioner, marking continued leadership instability at the agency. Separately, the agency rejected a closely tracked lung cancer drug, a setback for the sponsor. The rejection's specific drug and rationale are not detailed in the source.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 4 h ago2 sourcesEvidence: Reported
Published 2 d ago8 sourcesEvidence: Unknown
Published 2 d ago11 sourcesEvidence: Reported
Published 2 d ago6 sourcesEvidence: Reported
Published 2 d ago16 sourcesEvidence: Reported
Published 2 d ago8 sourcesEvidence: Reported